Scholarlink

Purpose <p>This study was conducted to evaluate the level of hope and adherence to medication in women with breast cancer in the presence of another chronic disease.</p> Methods <p>The cross-sectional study was conducted in March-August 2022 with women with breast cancer with (CVD group) and without (Non-CVD group) cardiovascular disease as a chronic disease. Data were collected with the 'Individual Information Form', 'Herth Hope Scale' and 'Medication Adherence and Prescription Writing Scale'. Independent Sample T-test, Mann Whitney U Test, Chi-Square Test and Correlation Analysis were used to analyze the data.</p> Results <p>Adherence to medication levels of the patients were higher with a mean score of 8.55 ± 2.16 in the CVD group and 8.33 ± 2.14 in the Non-CVD group and there was no difference between the two groups (p &lt; 0.05). When the hope levels of the patients were evaluated; the hope level of the CVD group was 69.57 ± 9.58 and the hope level of the Non-CVD group was 74.96 ± 7.98. The hope level of the CVD group was lower than that of the Non-CVD group (p &lt; 0.001, Cohen’s <i>d</i> = 0.61).</p> Conclusion <p>In women, the presence of a chronic (cardiovascular) disease in addition to breast cancer does not affect medication adherence but negatively affects the level of hope.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Women’s adherence to medication and hope in the presence of another chronic disease besides breast cancer: a cross-sectional study

  • 期刊论文

  • 发表日期：

    2025年9月22日

查看全文
  • Figen Akay,
  • Ayşe Özkaraman,
  • Öznur Bal

摘要

Purpose

This study was conducted to evaluate the level of hope and adherence to medication in women with breast cancer in the presence of another chronic disease.

Methods

The cross-sectional study was conducted in March-August 2022 with women with breast cancer with (CVD group) and without (Non-CVD group) cardiovascular disease as a chronic disease. Data were collected with the 'Individual Information Form', 'Herth Hope Scale' and 'Medication Adherence and Prescription Writing Scale'. Independent Sample T-test, Mann Whitney U Test, Chi-Square Test and Correlation Analysis were used to analyze the data.

Results

Adherence to medication levels of the patients were higher with a mean score of 8.55 ± 2.16 in the CVD group and 8.33 ± 2.14 in the Non-CVD group and there was no difference between the two groups (p < 0.05). When the hope levels of the patients were evaluated; the hope level of the CVD group was 69.57 ± 9.58 and the hope level of the Non-CVD group was 74.96 ± 7.98. The hope level of the CVD group was lower than that of the Non-CVD group (p < 0.001, Cohen’s d = 0.61).

Conclusion

In women, the presence of a chronic (cardiovascular) disease in addition to breast cancer does not affect medication adherence but negatively affects the level of hope.